Javascript must be enabled to continue!
Albumin Levels before Therapy and Clinicopathological Parameters of Lung Cancer Patients
View through CrossRef
Highlights
A notable finding was the significant relationship between albumin levels and ECOG scores, emphasizing the potential of albumin as an indicator of functional status in lung cancer patients.
The research provided a comprehensive analysis of the correlation between albumin levels and various clinicopathological conditions.
Background: Serum albumin levels provide an objective measure of malnutrition. Albumin plays crucial roles in maintaining intravascular oncotic pressure, facilitating substance transport, and acting as a free radical scavenger. The progression of tumors, including lung cancer, is closely associated with malnutrition and cancer-related inflammation, which suppress albumin synthesis. Therefore, albumin can serve as a biomarker for assessing lung cancer progression. Low albumin levels are linked to poor prognosis. Objective: The aim of this study was to examine the relationship between albumin levels and lung cancer. Material and Method: This study included 130 lung cancer patients who underwent albumin testing. A cross-sectional study was conducted using medical records of patients diagnosed with lung cancer from January 2023 to December 2023. Data were collected on various factors, including age, gender, smoking status, cancer history, clinical symptoms, histopathological type, cancer stage, EGFR mutation status, ECOG score, clinical pleural effusion, Visual Analog Scale (VAS), and Body Mass Index (BMI). Result: The study sample was predominantly male (71.5%), aged over 50 years (76.9%), and active smokers (34.6%). Common symptoms included cough (83.8%) and shortness of breath (72.3%), with pleural effusion present in 53.8%. The majority had a moderate VAS score (46.9%) and were classified as underweight based on BMI (54.6%). Most patients were at stage IVA (63.0%), had an ECOG score of 1 (43.8%), and were diagnosed with adenocarcinoma (73.8%). A significant relationship was found between ECOG scores and albumin levels, with 70.6% of hypoalbuminemic samples having an ECOG score of 3 (p < 0.005). Conclusion: A significant relationship was observed between albumin levels and ECOG scores in lung cancer patients.
Title: Albumin Levels before Therapy and Clinicopathological Parameters of Lung Cancer Patients
Description:
Highlights
A notable finding was the significant relationship between albumin levels and ECOG scores, emphasizing the potential of albumin as an indicator of functional status in lung cancer patients.
The research provided a comprehensive analysis of the correlation between albumin levels and various clinicopathological conditions.
Background: Serum albumin levels provide an objective measure of malnutrition.
Albumin plays crucial roles in maintaining intravascular oncotic pressure, facilitating substance transport, and acting as a free radical scavenger.
The progression of tumors, including lung cancer, is closely associated with malnutrition and cancer-related inflammation, which suppress albumin synthesis.
Therefore, albumin can serve as a biomarker for assessing lung cancer progression.
Low albumin levels are linked to poor prognosis.
Objective: The aim of this study was to examine the relationship between albumin levels and lung cancer.
Material and Method: This study included 130 lung cancer patients who underwent albumin testing.
A cross-sectional study was conducted using medical records of patients diagnosed with lung cancer from January 2023 to December 2023.
Data were collected on various factors, including age, gender, smoking status, cancer history, clinical symptoms, histopathological type, cancer stage, EGFR mutation status, ECOG score, clinical pleural effusion, Visual Analog Scale (VAS), and Body Mass Index (BMI).
Result: The study sample was predominantly male (71.
5%), aged over 50 years (76.
9%), and active smokers (34.
6%).
Common symptoms included cough (83.
8%) and shortness of breath (72.
3%), with pleural effusion present in 53.
8%.
The majority had a moderate VAS score (46.
9%) and were classified as underweight based on BMI (54.
6%).
Most patients were at stage IVA (63.
0%), had an ECOG score of 1 (43.
8%), and were diagnosed with adenocarcinoma (73.
8%).
A significant relationship was found between ECOG scores and albumin levels, with 70.
6% of hypoalbuminemic samples having an ECOG score of 3 (p < 0.
005).
Conclusion: A significant relationship was observed between albumin levels and ECOG scores in lung cancer patients.
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Blunt Chest Trauma and Chylothorax: A Systematic Review
Blunt Chest Trauma and Chylothorax: A Systematic Review
Abstract
Introduction: Although traumatic chylothorax is predominantly associated with penetrating injuries, instances following blunt trauma, as a rare and challenging condition, ...
Abstract SY38-02: Clinical investigations of obesity in cancer: BMI and other confounders
Abstract SY38-02: Clinical investigations of obesity in cancer: BMI and other confounders
Abstract
Obesity has been linked with increased incidence and worse outcomes of at least 13 human cancers. For other cancers, our understanding of their relationship...
Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer
Lung uptake on I-131 therapy and short-term outcome in patients with lung metastasis from differentiated thyroid cancer
Abstract
Objective
It is sometimes difficult to assess I-131 lung uptake at the initial I-131 therapy because of strong artifacts from I-131 upta...
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract
Background: Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide. It is the third most common cancer in men in Algeri...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract
Introduction: In the past decade, advances in genetics have led to the discovery of numerous lung cancer susceptibility variants. The majority of these vari...

